CAS: 15291-75-5; Ginkgolide A

该化合物是一种主要来自Ginkgo biloba 叶叶的二叶细胞内酯化合物, 作为一种重要的生物活性成分, 它具有显著的药理特性, 特别是作为一种选择性的小板活性因(PAF)受体异同体, 该机制是其在炎症, 心血管紊乱和...

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号112574-07-9 | CAS号15291-77-7 银杏内酯B | CAS号15291-75-5 银杏内酯 A | CAS号15291-75-5 银杏内酯 A

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7598291-B2
    优先权日:2004-09-02
    标题 :Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
    发明人:NIMNI MARCEL; HAN BO
    权利人:NIMNI MARCEL; HAN BO
    摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid, a lipoic acid analogue or derivative, a bioflavonoid, a constituent of ginkgo, or an isoflavone. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.

    专利号:US-2010160244-A1
    优先权日:2004-09-02
    标 题 :Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin
    发明人:NIMNI MARCEL; HAN BO
    权利人:NIMNI MARCEL; HAN BO
    摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids or hydrolyzed whey protein; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid or a lipoic acid analogue or derivative. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.

    专利号:US-6693091-B2
    优先权日:2002-03-29
    标 题 :Analogs of terpene trilactones from Ginkgo biloba for bioorganic and imaging studies
    发明人:STROMGAARD KRISTIAN; SUEHIRO MAKIKO; NAKANISHI KOJI
    权利人:UNIV COLUMBIA
    摘要:A compound having the structure: n wherein R 1 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; n wherein R 2 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; n wherein R 3 is H or OH; n wherein R 4 is H, OH, a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety; and n wherein at least one of R 1 , R 2 , R 3 , or R 4 is a photoactivatable moiety, a fluorescent moiety, or a radioactive moiety. Optically pure enantiomers and salts of the compound are also described. Also, the synthesis of the compound, and uses of the compound, such as in a method for detecting the localization of, or identifying, receptors, enzymes or other targets, whether in a cell or in a subject.

    专利号:US-2009221019-A1
    优先权日:2005-06-22
    标 题:Core-Modified Terpene Trilactones From Ginkgo Biloba Extract and Biological Evaluation Thereof
    发明人:NAKANISHI KOJI; DZYUBA SERGEI; ISHII HIDEKI
    权利人:NAKANISHI KOJI; DZYUBA SERGEI; ISHII HIDEKI
    摘要:Lactone-rings of ginkgolides are converted into the corresponding tetrahydrofuran moieties via DIBAL-H reduction followed by deoxygenation of the formed lactols with Et 3 SiH/BF 3 Et 2 O producing a series of lactol-free ginkgolides. The present invention also relates to synthesis of hydroxyl-free, or hydroxyl-free and lactone-free, ginkgolides and bilobalides.

    专利号:US-12102085-B2
    优先权日:2013-10-18
    标题 :Insecticidal active mixtures comprising carboxamide compound
    发明人:SIKULJAK TATJANA; GEWEHR MARKUS
    权利人:BASF AGROCHEMICAL PRODUCTS BV
    摘要:The present invention relates to pesticidal mixtures comprising as active compound I an insecticidal active carboxamide derivative and at least one active compound II selected from a group M comprising acteylcholine esterase inhibitors, GABA-gated chloride channel antagonists, sodium channel modulators, nicotinic acteylcholine receptor agonists/antagonists, allosteric nicotinic acetylcholine receptor activators, chloride channel activators, juvenile hormone mimics, homopteran feeding blockers, mit grow inhibitors, inhibitors of mitochondrial ATP synthase, uncouplers of the oxidative phosphorylation, inhibitors of the chitin biosynthesis, moulting disruptors, ecdyson receptor agonists, octamin receptor agonists, inhibitors of the MET, voltage-dependent sodium channel blockers, inhibitors of the lipid synthesis, ryanodine receptor modulators and other compounds as defined in the description, in synergistically effective amounts.The invention relates further to methods and use of these mixtures for combating and controlling insects, arachnids or nematodes in and on plants, and for protecting such plants being infested with pests, especially also for protecting plant proparagation material, such as seeds.

    专利号:CN-108117561-A
    优先权日:2016-11-30
    标 题 :A kind of mesylate amine ginkgolide B metabolite and its synthesis and purification method
    成都草源康生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.caoyuankang.cn
    电话: 13438890071👤
    📞成都草源康生物科技有限公司 ⚠️参考联系方式

    销售电话:13438890071
    邮箱:3003796343@qq.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都科程生物科技开发有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cogon-chem.com
    电话: 028-85171192👤
    📞成都科程生物科技开发有限公司 ⚠️参考联系方式

    销售电话:028-85171192
    邮箱:cogon_chem@hotmail.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏鹏鹞药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pengyaopharm.com
    电话: 0510-87072885👤
    📞江苏鹏鹞药业有限公司 ⚠️参考联系方式

    销售电话:0510-87072885
    邮箱:PY@pengyaopharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ma S, Liu X, Xu Q, Zhang X. Transport of ginkgolides with different lipophilicities based on an hCMEC/D3 cell monolayer as a blood-brain barrier cell model. Life Sci. 2014 Oct 2;114(2):93-101. doi: 10.1016/j.lfs.2014.08.006. Epub 2014 Aug 17. doi: 10.1002/bmc.3515. Epub 2015 Jul 23. doi: 10.1016/j.intimp.2015.02.001. Epub 2015 Feb 11. doi: 10.1016/j.jpba.2014.07.030. Epub 2014 Aug 2. doi: 10.4062/biomolther.2015.077. Epub 2016 Jan 1.
    6: Wang X, Jiang CM, Wan HY, Wu JL, Quan WQ, Wu KY, Li D. Neuroprotection against permanent focal cerebral ischemia by ginkgolides A and B is associated with obstruction of the mitochondrial apoptotic pathway via inhibition of c-Jun N-terminal kinase in rats. J Neurosci Res. 2014 Feb;92(2):232-42. doi: 10.1002/jnr.23306. Epub 2013 Nov 4. doi: 10.1055/s-0032-1314965. Epub 2012 Jun 14. doi: 10.1124/dmd.112.045013. Epub 2012 Mar 5. doi: 10.1016/j.jpba.2015.10.029. Epub 2015 Oct 26. doi: 10.1016/j.jpba.2016.04.035. Epub 2016 Apr 25. Chinese. doi: 10.1074/jbc.M109.079319. Epub 2010 Jan 27.
    13: Si HH, Geng T, Sun XP, Zhao J, Xue J. [Absolute bioavailability of ginkgolide compounds in rats]. Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(14):2882-6. Chinese. doi: 10.1016/j.jss.2011.03.018. Epub 2011 Apr 1.

    合成参考文献


    参考文献:10.1016/s0024-3205(01)01557-0
    摘要:Sasaki K, Hatta S, Wada K, Ueda N, Yoshimura T, Endo T, Sakata M, Tanaka T, Haga M. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci. 2002 Feb 22;70(14):1657–67. doi: 10.1016/s0024-3205(01)01557-0.
    参考文献:10.1021/jf011682s
    摘要:Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA. Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem. 2002 May 22;50(11):3150–5. doi: 10.1021/jf011682s.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知